Bronchiectasis patients have a large amount of sputum and secretions. Acetylcysteiene, nebulizer, bronchiectasis, normal saline
Conditions
Interventions
acetylcysteine nebulizer (300mg/3ml) 3 ml bid,normal saline nebulizer 3 ml bid
Experimental Drug,Experimental Drug
acetylcysteine nebulizer,normal saline nebulizer
Sponsors
None listed
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Patients aged 18 years or older. 2. Diagnosed with bronchiectasis by a physician, based on symptoms and chest imaging (x-ray or CT scan). 3. Willing to participate by signing consent.
Exclusion criteria
Exclusion criteria: 1. Patients who have not quit smoking or have quit smoking for less than 6 months. 2. Patients diagnosed with cystic fibrosis. 3. Patients with pulmonary function test results showing FEV1 lower than 30%. 4. Pregnant patients. 5. Participants who decline or wish to withdraw from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| sputum over 2 weeks sputum volume | — |
Secondary
| Measure | Time frame |
|---|---|
| cough symptoms, fatigue, and quality of life through assessments over 2 weeks St. George's Respiratory Questionnaire (SGRQ), modified Medical Research Council (mMRC) dyspnea scale, COPD Assessment Test (CAT), and the Thai version of the Leicester Cough Questionnaire | — |
Countries
Thailand
Contacts
Public ContactSupiya Kijlertsuphasri
Faculty of Medicine Ramathibodi Hospital
Outcome results
None listed